![]() |
|
|
PJ Pauwels, HP Van Assouw and JE Leysen
Department of Biochemical Pharmacology, Janssen Research Foundation, Beerse, Belgium.
Regulation of the appearance of dihydropyridine-binding sites was studied in primary cultures of chick myotubes. Labeling of surface dihydropyridine-binding sites on intact myotubes at 37 degrees was achieved with (+)-[3H]PN 200-110. The appearance of the sites was prevented in a calcium-free medium using 1.8 mM EGTA, in accordance with the presumed Ca2+ dependency of the appearance of dihydropyridine- binding sites in skeletal muscle cells. Chronic treatment of myotubes with isoproterenol or various other drugs did not modulate either the Bmax or Kd value of the (+)-[3H]PN 200-110 binding to the membrane preparation of treated myotubes (control values were: Kd = 0.16 nm, Bmax = 556 fmol/mg of protein), suggesting a lack of heterologous regulation via beta-adrenergic receptor stimulation. However, depolarization of intact myotubes, either by 47 mM K+ or 10(-5) M veratridine, provoked a 3-fold increase in the Bmax value of (+)-[3H]PN 200-110 binding measured on the intact muscle cells without affecting the Kd value. The effect was reversed upon repolarization of the cells. Depolarizing conditions did not affect the binding on a membrane preparation of the myotubes. Hence, depolarization appeared to specifically trigger the appearance of (+)-[3H]PN 200-110 binding sites on intact myotubes; several hypotheses which could explain the involved mechanism are discussed.
This article has been cited by other articles:
![]() |
R. Araya, J. L. Liberona, J. C. Cardenas, N. Riveros, M. Estrada, J. A. Powell, M. A. Carrasco, and E. Jaimovich Dihydropyridine Receptors as Voltage Sensors for a Depolarization-evoked, IP3R-mediated, Slow Calcium Signal in Skeletal Muscle Cells J. Gen. Physiol., December 30, 2002; 121(1): 3 - 16. [Abstract] [Full Text] [PDF] |
||||